Alkaline phosphatase formulations
US-12048735-B2 · Jul 30, 2024 · US
High ibuprofen content granules and their preparation and their use in pharmaceutical dosage forms
US8940329B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940329-B2 |
| Application number | US-26066205-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 28, 2005 |
| Priority date | Jun 30, 2004 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Described are granules composed at least of a substantial amount of ibuprofen, at least one pharmaceutically-acceptable super disintegrant, and at least one pharmaceutically-acceptable binder different from the super disintegrant(s), the super disintegrant(s) being substantially uniformly dispersed throughout the granules. The methods for preparing such granules are described. The granules are useful in forming solid dosage forms such as filled capsules or compressed solid dosage forms.
First claim
Opening claim text (preview).
That which is claimed is: 1. Pharmaceutical granules consisting of (i) 75 wt % or more of ibuprofen, (ii) in the range of about 0.5 to about 10 wt % of sodium starch glycolate, (iii) in the range of about 2 to about 14.5 wt % of at least one pharmaceutically-acceptable binder, which binder is different from sodium starch glycolate, (iv) in the range of about 0.01 to about 2.0 wt % of at least one pharmaceutically-acceptable wetting agent, and optionally (v) in the range of about 0.…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K9/2077Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8940329B2 cover?
- Described are granules composed at least of a substantial amount of ibuprofen, at least one pharmaceutically-acceptable super disintegrant, and at least one pharmaceutically-acceptable binder different from the super disintegrant(s), the super disintegrant(s) being substantially uniformly dispersed throughout the granules. The methods for preparing such granules are described. The granules are …
- Who is the assignee on this patent?
- Hu Patrick C, Lambeth Gregory H, Malcolm Arcelio J, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K9/2077. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).